Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer

Go back to Zymeworks Appoints Dr. Adam Schayowitz as Acting Chief Development Officer
(NASDAQ: ZYME) Delayed: 26.24 -0.2 (0.76%)
Previous Close $26.44    52 Week High
Open $26.62    52 Week Low
Day High $26.99    P/E N/A 
Day Low $26.03    EPS
Volume 1,358,913